Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FPR2 | P25090 | 5/20 | 0.48 |
| ▸ | CSNK2A2 | P19784 | 2/20 | 0.40 |
| ▸ | CSNK2A1 | P68400 | 2/20 | 0.40 |
| ▸ | ALPG | P10696 | 2/20 | 0.39 |
| ▸ | PLAA | Q9Y263 | 1/20 | 0.39 |
| ▸ | ALPL | P05186 | 1/20 | 0.38 |
| ▸ | ESR1 | P03372 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17669581 | 0.83 | FPR2 (0.52) | FPR2CSNK2A2CSNK2A1ALPGPLAA | |
| SCHEMBL3587986 | 0.83 | FPR2 (0.49) | FPR2CSNK2A2CSNK2A1ALPGPLAA | |
| SCHEMBL371254 | 0.81 | ALPG (0.56) | FPR2ALPGPLAAALPLESR1 | |
| SCHEMBL12037553 | 0.79 | ALPG (0.47) | FPR2ALPGPLAAALPLSMN1; SMN2 | |
| SCHEMBL13310633 | 0.77 | FPR2 (0.45) | FPR2ALPGPLAAALPLESR1 | |
| SCHEMBL10292434 | 0.77 | FPR2 (0.45) | FPR2ALPGPLAAALPLESR1 | |
| SCHEMBL20724674 | 0.77 | FPR2 (0.45) | FPR2CSNK2A2CSNK2A1ALPGPLAA | |
| SCHEMBL16577159 | 0.77 | FPR2 (0.48) | FPR2ALPGPLAAALPLESR1 | |
| SCHEMBL15501010 | 0.77 | CSNK2A2 (0.46) | FPR2CSNK2A2CSNK2A1ESR1SMN1; SMN2 | |
| SCHEMBL31590621 | 0.76 | AGTR1 (0.51) | FPR2ALPGPLAAALPLALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3939972-A1 | TRIAZINE BASED RADIOPHARMACEUTICALS AND RADIOIMAGING AGENTS | Molecular Insight Pharmaceuticals, Inc. (US) | 2022-01-19 | — | — | EP | disclosed |